These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Practical approach to diagnosis of bland-looking spindle cell lesions of the breast. Magro G; Salvatorelli L; Puzzo L; Piombino E; Bartoloni G; Broggi G; Vecchio GM Pathologica; 2019 Dec; 111(4):344-360. PubMed ID: 31965112 [TBL] [Abstract][Full Text] [Related]
3. STAT6 expression in spindle cell lesions of the breast: An immunohistochemical study of 48 cases. Magro G; Spadola S; Motta F; Palazzo J; Catalano F; Vecchio GM; Salvatorelli L Pathol Res Pract; 2018 Oct; 214(10):1544-1549. PubMed ID: 30072169 [TBL] [Abstract][Full Text] [Related]
4. Benign spindle cell lesions of the breast: a diagnostic approach to solitary fibrous tumour, nodular pseudoangiomatous stromal hyperplasia and nodular fasciitis. Naso JR; Chiu CG; Goecke ME; Chang D; Shiau CJ J Clin Pathol; 2019 Jun; 72(6):438-442. PubMed ID: 30739079 [TBL] [Abstract][Full Text] [Related]
5. Benign and malignant spindle cell lesions of the breast. Brogi E Semin Diagn Pathol; 2004 Feb; 21(1):57-64. PubMed ID: 15074560 [TBL] [Abstract][Full Text] [Related]
6. Myofibroblastic, fibroblastic and myoid lesions of the breast. Krings G; McIntire P; Shin SJ Semin Diagn Pathol; 2017 Sep; 34(5):427-437. PubMed ID: 28751104 [TBL] [Abstract][Full Text] [Related]
7. Low to Intermediate (Borderline) Grade Breast Spindle Cell Lesions on Needle Biopsy: Diagnostic Approach and Clinical Management. Russell DH; Montgomery EA; Susnik B Adv Anat Pathol; 2022 Sep; 29(5):309-323. PubMed ID: 35838633 [TBL] [Abstract][Full Text] [Related]
8. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Suster S; Fisher C; Moran CA Am J Surg Pathol; 1998 Jul; 22(7):863-72. PubMed ID: 9669348 [TBL] [Abstract][Full Text] [Related]
9. Nodular fasciitis of the male breast: a case report. Squillaci S; Tallarigo F; Patarino R; Bisceglia M Int J Surg Pathol; 2007 Jan; 15(1):69-72. PubMed ID: 17172503 [TBL] [Abstract][Full Text] [Related]
10. Lipomatous myofibroblastoma: a potential diagnostic pitfall in the spectrum of the spindle cell lesions of the breast. Magro G; Michal M; Vasquez E; Bisceglia M Virchows Arch; 2000 Nov; 437(5):540-4. PubMed ID: 11147176 [TBL] [Abstract][Full Text] [Related]
11. Benign spindle cell tumor of the breast with prominent adipocytic component. Magro G; Bisceglia M; Pasquinelli G Ann Diagn Pathol; 1998 Oct; 2(5):306-11. PubMed ID: 9845754 [TBL] [Abstract][Full Text] [Related]
12. Spindle cell lesions of the breast--the pathologic differential diagnosis. Tse GM; Tan PH; Lui PC; Putti TC Breast Cancer Res Treat; 2008 May; 109(2):199-207. PubMed ID: 17636400 [TBL] [Abstract][Full Text] [Related]
13. Fibrohistiocytic lipoma: twelve cases of a previously undescribed benign fatty tumor. Marshall-Taylor C; Fanburg-Smith JC Ann Diagn Pathol; 2000 Dec; 4(6):354-60. PubMed ID: 11149965 [TBL] [Abstract][Full Text] [Related]
14. Spindle Cell Lesions of the Breast: A Diagnostic Algorithm. Ni Y; Tse GM Arch Pathol Lab Med; 2023 Jan; 147(1):30-37. PubMed ID: 35976671 [TBL] [Abstract][Full Text] [Related]
15. Spindle cell lesions of the breast: a diagnostic approach. Rakha EA; Brogi E; Castellano I; Quinn C Virchows Arch; 2022 Jan; 480(1):127-145. PubMed ID: 34322734 [TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors: a diagnostic pitfall. Barak S; Wang Z; Miettinen M Am J Surg Pathol; 2012 Sep; 36(9):1404-9. PubMed ID: 22531174 [TBL] [Abstract][Full Text] [Related]
17. Benign spindle cell tumors of the mammary stroma: diagnostic criteria, classification, and histogenesis. Magro G; Michal M; Bisceglia M Pathol Res Pract; 2001; 197(7):453-66. PubMed ID: 11482575 [TBL] [Abstract][Full Text] [Related]
18. Spindle cell lipoma-like tumor, solitary fibrous tumor and myofibroblastoma of the breast: a clinico-pathological analysis of 13 cases in favor of a unifying histogenetic concept. Magro G; Bisceglia M; Michal M; Eusebi V Virchows Arch; 2002 Mar; 440(3):249-60. PubMed ID: 11889594 [TBL] [Abstract][Full Text] [Related]
19. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Bhattacharya B; Dilworth HP; Iacobuzio-Donahue C; Ricci F; Weber K; Furlong MA; Fisher C; Montgomery E Am J Surg Pathol; 2005 May; 29(5):653-9. PubMed ID: 15832090 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]